Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victoria M Pratt

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 18, 2022
Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG)Marwan K Tayeh, Andrea Gaedigk, Matthew P Goetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2024
Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in OncologySharon P Shriver, Devon Adams, Brittany Avin McKelvey, et al.
The Journal of Molecular Diagnostics : JMD|June 23, 2009
CpG methylation analysis--current status of clinical assays and potential applications in molecular diagnostics: a report of the Association for Molecular PathologyAntonia R Sepulveda, Dan Jones, Shuji Ogino, et al.
The Journal of Molecular Diagnostics : JMD|May 21, 2021
Characterization of Reference Materials with an Association for Molecular Pathology Pharmacogenetics Working Group Tier 2 Status: CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, and GGCX: A GeT-RM Collaborative ProjectVictoria M Pratt, Amy Turner, Ulrich Broeckel, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 19, 2005
Detection of 677CT/1298AC "double variant" chromosomes: implications for interpretation of MTHFR genotyping resultsNicholas M Brown, Victoria M Pratt, Arlene Buller, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 13, 2019
Response to Gammal et alJason L Vassy, Annjanette Stone, John T Callaghan, et al.
The Journal of Molecular Diagnostics : JMD|August 12, 2019
Characterization of Reference Materials for Genetic Testing of CYP2D6 Alleles: A GeT-RM Collaborative ProjectAndrea Gaedigk, Amy Turner, Robin E Everts, et al.
The Journal of Molecular Diagnostics : JMD|December 17, 2013
Revisiting oversight and regulation of molecular-based laboratory-developed tests: a position statement of the Association for Molecular PathologyAndrea Ferreira-Gonzalez, Rajyasree Emmadi, Stephen P Day, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 3, 2018
Pharmacogenetic testing in the Veterans Health Administration (VHA): policy recommendations from the VHA Clinical Pharmacogenetics SubcommitteeJason L Vassy, Annjanette Stone, John T Callaghan, et al.
Pharmacogenetics and Genomics|November 30, 2018
Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapyKimberly S Collins, Victoria M Pratt, Wesley M Stansberry, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 18, 2022
Clinical pharmacogenomic testing and reporting: A technical standard of the American College of Medical Genetics and Genomics (ACMG)Marwan K Tayeh, Andrea Gaedigk, Matthew P Goetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2024
Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in OncologySharon P Shriver, Devon Adams, Brittany Avin McKelvey, et al.
The Journal of Molecular Diagnostics : JMD|June 23, 2009
CpG methylation analysis--current status of clinical assays and potential applications in molecular diagnostics: a report of the Association for Molecular PathologyAntonia R Sepulveda, Dan Jones, Shuji Ogino, et al.
The Journal of Molecular Diagnostics : JMD|May 21, 2021
Characterization of Reference Materials with an Association for Molecular Pathology Pharmacogenetics Working Group Tier 2 Status: CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, and GGCX: A GeT-RM Collaborative ProjectVictoria M Pratt, Amy Turner, Ulrich Broeckel, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 19, 2005
Detection of 677CT/1298AC "double variant" chromosomes: implications for interpretation of MTHFR genotyping resultsNicholas M Brown, Victoria M Pratt, Arlene Buller, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 13, 2019
Response to Gammal et alJason L Vassy, Annjanette Stone, John T Callaghan, et al.
The Journal of Molecular Diagnostics : JMD|August 12, 2019
Characterization of Reference Materials for Genetic Testing of CYP2D6 Alleles: A GeT-RM Collaborative ProjectAndrea Gaedigk, Amy Turner, Robin E Everts, et al.
The Journal of Molecular Diagnostics : JMD|December 17, 2013
Revisiting oversight and regulation of molecular-based laboratory-developed tests: a position statement of the Association for Molecular PathologyAndrea Ferreira-Gonzalez, Rajyasree Emmadi, Stephen P Day, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 3, 2018
Pharmacogenetic testing in the Veterans Health Administration (VHA): policy recommendations from the VHA Clinical Pharmacogenetics SubcommitteeJason L Vassy, Annjanette Stone, John T Callaghan, et al.
Pharmacogenetics and Genomics|November 30, 2018
Analytical validity of a genotyping assay for use with personalized antihypertensive and chronic kidney disease therapyKimberly S Collins, Victoria M Pratt, Wesley M Stansberry, et al.
Pageof 9